Astonea Labs Limited
BBSE:ASTONEALAB323.00
INR
-1.00
(-0.31%)
ISIN
INE0TG901011
Return %
Stock
S&P 500
1Y
101.88
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Ashish Gulati
- Full Time Employees
- 195
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Panchkula India
- IPO Date
- Jun 3, 2025
- Similar Companies
- Business
- Astonea Labs Limited is an India-based pharmaceutical, cosmeceutical, and personal care manufacturing company engaged in the research, development, formulation, and commercialization of healthcare and wellness products. Founded in 2016 and headquartered in Panchkula, Haryana, India, the company operates primarily as a contract development and manufacturing organization (CDMO), third-party formulation producer, and private-label partner for domestic and multinational pharmaceutical and consumer wellness brands, while also marketing products under proprietary brand names. The company's core business is organized into multiple therapeutic and consumer categories, encompassing pharmaceutical formulations, dermatology and cosmeceuticals, personal care, nutraceuticals, and ayurvedic formulations. Its pharmaceutical formulation portfolio comprises oral solid and liquid dosage forms, including generic and branded tablets, hard and soft gelatin capsules, dry syrups, and oral suspensions; topical formulations, including antibacterial creams, antifungal ointments, analgesic gels, and medicated dusting powders; and specialized liquid preparations, including sterile ophthalmic, otic, and nasal drops. Its dermatological and cosmeceutical segment includes targeted skincare solutions such as anti-acne cleansers, broad-spectrum sunscreens, skin-brightening creams, hydrating lotions, anti-aging serums, and specialized skin barrier ointments. Its personal care and wellness division manufactures hair care products, including therapeutic shampoos, conditioners, and hair revitalization serums; personal hygiene products, including body washes, medicated soaps, and hand sanitizers; and nutraceutical supplements, including multivitamins, mineral complexes, herbal syrups, and immunity-enhancing formulations. Additionally, the company provides turnkey manufacturing services, including custom formulation development, analytical testing, regulatory documentation support, stability testing, and private-label packaging. Astonea Labs Limited maintains manufacturing facilities in Northern India built to adhere to Good Manufacturing Practice (GMP) and World Health Organization (WHO-GMP) guidelines, serving healthcare institutions, government procurement agencies, pharmacy distribution networks, and consumer health brands across India, with targeted exports to emerging markets in Southeast Asia, Africa, and the Commonwealth of Independent States (CIS). In recent developments, the company has completed its public listing on the BSE SME platform to fund production line modernizations and working capital requirements; expanded its cleanroom and automated packaging capacity to increase output volumes for topical and liquid formulations; introduced dedicated production lines for specialized dermatological and cosmeceutical products; and established new contract manufacturing alliances with regional pharmaceutical distributors and digital-first personal care brands to broaden its commercial manufacturing footprint.